ActCells.com
Animal Cell Therapies has partnered with a select group of researchers, scientists and collaborators from the U.S. and abroad to create an in-house program to grow and expand well-characterized animal stem cells, in a scientific setting, under Good Laboratory Practices (GLP) conditions, and eventually, develop into a Current Good Manufacturing Practices (cGMP) facility. Our goal is to provide pure, potent, reliable, pathogen-free, animal stem cells. During this phase, Animal Cell Therapies plans to optimize stem cell storage while improving stem cell transportation procedures and delivery techniques. Animal Cell Therapies also identifies, validates, and markets unique diagnostic tests for companion animals. ACT is currently in the second phase of validating a cancer screening blood test for dogs.
